WithdrawnPHASE2, PHASE3NCT04137978
Study Evaluating Patients With Cystinuria
Studying Cystinuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Advicenne Pharma
- Principal Investigator
- Luc-André Granier, M.D., M.DAdvicenne Pharma
- Intervention
- ADV7103(drug)
- Eligibility
- 70 years · All sexes
- Timeline
- 2024 – 2025
Study locations (13)
- Cliniques Universitaires Saint-Luc, Brussels, Belgium
- UZ Leuven, Gasthuisberg Hospital, Leuven, Belgium
- CHU de Bordeaux - Hôpital Pellegrin, Bordeaux, France
- Centre Hospitalier Universitaire de Lyon, Bron, France
- CHU Grenoble, Grenoble, France
- CHRU Lille, Lille, France
- CHU Pitié-Salpétrière, Paris, France
- Hôpital Necker AP-HP, Paris, France
- Hôpital Necker Enfants Malades, Paris, France
- Hôpital Ténon - Explorations fonctionnelles Mutlidisciplinaires et INSERM UMR S 1155, Paris, France
- Hôpital Américain CHU de Reims, Reims, France
- CHU Reims, Reims, France
- CHU Purpan, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04137978 on ClinicalTrials.govOther trials for Cystinuria
Additional recruiting or active studies for the same condition.